Associated Banc Corp Clovis Oncology, Inc. Transaction History

Associated Banc Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 11, 2021	SELL	$4.13 - $6.41 $685 - $1,064	-166 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.82 - $7.72 $800 - $1,281	166 New	166 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

Stay updated on Associated Banc Corp with notifications on news.